237 related articles for article (PubMed ID: 20560844)
1. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
Lisowska A; Madry E; Pogorzelski A; Szydłowski J; Radzikowski A; Walkowiak J
Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
[TBL] [Abstract][Full Text] [Related]
2. Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection.
Lisowska A; Wójtowicz J; Walkowiak J
Acta Biochim Pol; 2009; 56(4):631-4. PubMed ID: 19997657
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin concentration in children affected by SIBO.
Fundarò C; Fantacci C; Ansuini V; Giorgio V; Filoni S; Barbaro F; Gasbarrini A; Rossi C
Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1328-35. PubMed ID: 22195368
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth.
Montalto M; Santoro L; Dalvai S; Curigliano V; D'Onofrio F; Scarpellini E; Cammarota G; Panunzi S; Gallo A; Gasbarrini A; Gasbarrini G
Dig Dis; 2008; 26(2):183-6. PubMed ID: 18431069
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for small bowel bacterial overgrowth in cystic fibrosis.
Fridge JL; Conrad C; Gerson L; Castillo RO; Cox K
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):212-8. PubMed ID: 17255834
[TBL] [Abstract][Full Text] [Related]
6. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
De Lisle RC; Roach E; Jansson K
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
[TBL] [Abstract][Full Text] [Related]
7. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
[TBL] [Abstract][Full Text] [Related]
8. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.
Norkina O; Burnett TG; De Lisle RC
Infect Immun; 2004 Oct; 72(10):6040-9. PubMed ID: 15385508
[TBL] [Abstract][Full Text] [Related]
9. Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth.
Lisowska A; Pogorzelski A; Oracz G; Siuda K; Skorupa W; Rachel M; Cofta S; Piorunek T; Walkowiak J
J Cyst Fibros; 2011 Dec; 10(6):418-21. PubMed ID: 21767998
[TBL] [Abstract][Full Text] [Related]
10. Intestinal inflammation and impact on growth in children with cystic fibrosis.
Dhaliwal J; Leach S; Katz T; Nahidi L; Pang T; Lee JM; Strachan R; Day AS; Jaffe A; Ooi CY
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196
[TBL] [Abstract][Full Text] [Related]
11. Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children.
Donowitz JR; Haque R; Kirkpatrick BD; Alam M; Lu M; Kabir M; Kakon SH; Islam BZ; Afreen S; Musa A; Khan SS; Colgate ER; Carmolli MP; Ma JZ; Petri WA
mBio; 2016 Jan; 7(1):e02102-15. PubMed ID: 26758185
[TBL] [Abstract][Full Text] [Related]
12. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
Furnari M; De Alessandri A; Cresta F; Haupt M; Bassi M; Calvi A; Haupt R; Bodini G; Ahmed I; Bagnasco F; Giannini EG; Casciaro R
J Gastroenterol; 2019 Mar; 54(3):261-270. PubMed ID: 30232597
[TBL] [Abstract][Full Text] [Related]
13. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
Fallahi G; Motamed F; Yousefi A; Shafieyoun A; Najafi M; Khodadad A; Farhmand F; Ahmadvand A; Rezaei N
Turk J Pediatr; 2013; 55(5):475-8. PubMed ID: 24382526
[TBL] [Abstract][Full Text] [Related]
14. Evidence of intestinal inflammation in patients with cystic fibrosis.
Werlin SL; Benuri-Silbiger I; Kerem E; Adler SN; Goldin E; Zimmerman J; Malka N; Cohen L; Armoni S; Yatzkan-Israelit Y; Bergwerk A; Aviram M; Bentur L; Mussaffi H; Bjarnasson I; Wilschanski M
J Pediatr Gastroenterol Nutr; 2010 Sep; 51(3):304-8. PubMed ID: 20512061
[TBL] [Abstract][Full Text] [Related]
15. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A
Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615
[TBL] [Abstract][Full Text] [Related]
16. Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients.
Ricci JER; Chebli LA; Ribeiro TCDR; Castro ACS; Gaburri PD; Pace FHDL; Barbosa KVBD; Ferreira LEVVDC; Passos MDCF; Malaguti C; Delgado ÁHDA; Campos JD; Coelho AR; Chebli JMF
J Clin Gastroenterol; 2018 Jul; 52(6):530-536. PubMed ID: 28134633
[TBL] [Abstract][Full Text] [Related]
17. Small intestinal bacterial overgrowth in systemic sclerosis.
Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
[TBL] [Abstract][Full Text] [Related]
18. Luminal antigliadin antibodies in small intestinal bacterial overgrowth.
Riordan SM; McIver CJ; Wakefield D; Duncombe VM; Bolin TD; Thomas MC
Am J Gastroenterol; 1997 Aug; 92(8):1335-8. PubMed ID: 9260801
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a Cystic Fibrosis Enteropathy.
Adriaanse MP; van der Sande LJ; van den Neucker AM; Menheere PP; Dompeling E; Buurman WA; Vreugdenhil AC
PLoS One; 2015; 10(10):e0138062. PubMed ID: 26484665
[TBL] [Abstract][Full Text] [Related]
20. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
Bruzzese E; Raia V; Gaudiello G; Polito G; Buccigrossi V; Formicola V; Guarino A
Aliment Pharmacol Ther; 2004 Oct; 20(7):813-9. PubMed ID: 15379842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
